Taken together, our findings revealed that the IFNγ-LncRNA00364-STAT3-IFIT2 axis exhibits exciting anticancer effects and provide new insight into a possible novel therapeutic avenue in HCC. The gene discussed is IFIT2; the disease is hepatocellular carcinoma.